Germany Market Entry Navigator

Find your biggest Germany launch gaps.

The Germany Market Entry Navigator is a short self-assessment of your readiness across clinical validation, market access and commercial execution. It helps identify the questions that should be resolved before committing to a German launch model.

The Navigator is a starting point. Product-specific German market decisions require clinical, access and commercial validation. See the full MedTech market entry in Germany route.

The route

Seven stages — sequenced around your situation.

You do not need every stage. The Navigator identifies which stages matter for your situation and prioritises them into one plan.

01

Where you are today

Your current market position, portfolio, evidence base and commercial setup in Germany.

02

Gaps & priorities

What is missing across market access, KOL engagement, distribution, positioning and evidence — and what matters most.

03

Market access route

Reimbursement pathway, pricing signal, payer and stakeholder mapping, and the route into the German healthcare system.

04

Clinical validation

KOL engagement, advisory boards and the clinical evidence needed to support adoption and coverage.

05

Distribution & KOLs

Distributor search and qualification, reference-centre development and hospital access.

06

Commercial execution

Local market representation, sales execution and commercial operations delivered in Germany.

07

Sustainable growth

Wider hospital adoption, additional evidence and commercial expansion — a route that holds.

Fix Germany · Germany Commercial Diagnostic

Entered Germany — but the market is not performing?

The Germany Commercial Diagnostic identifies the causes behind weak distributor sales, few hospital customers, unclear positioning, reimbursement issues, pricing problems or low KOL engagement — and recommends a concrete go-to-market reset.

Weak distributor salesFew hospital customersUnclear positioningReimbursement issuesPricing problemsLow KOL engagement
  1. 1

    Situation review

    Current position, targets, distributor setup and evidence base.

  2. 2

    Gap analysis

    Market access, KOL engagement, distribution, positioning and pricing.

  3. 3

    Root-cause diagnosis

    Why adoption and revenue are below expectation.

  4. 4

    Go-to-market reset

    Prioritised actions to rebuild traction in Germany.

Next step

Map your route into Germany — or diagnose why it is underperforming.